(R)-Lansoprazole Dexlansoprazole CAS 138530-94-6 Assay 98.0~102.0% (HPLC) Pabrik
Ruifu Chemical Supply Lansoprazole Intermediates
Lansoprazole CAS 103577-45-3
Lansoprazole Chloride Senyawa CAS 127337-60-4
(R)-Lansoprazole Dexlansoprazole CAS 138530-94-6
Jeneng Kimia | (R) - Lansoprazole |
sinonim | R-(+)-Lansoprazole;Dexlansoprazole;2-[(R)-[[3-Metil-4-(2,2,2-trifluoroethoxy)-2-piridinil]metil]sulfinil]-1H-benzimidazole;T 168390;TAK 390;Lansoprazole Impurity 14;Dexlansoprazole Related Impurities 2;(R)-2-[[[3-Metil-4-(2,2,2-trifluoroethoxy)-2-piridil]metil]sulfinil]-1H-Benzimidazole; |
Nomer CAS | 138530-94-6 |
Nomer CAT | RF-PI1916 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C16H14F3N3O2S |
Bobot Molekul | 369.36 |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk Kristal Putih nganti Putih |
Kelarutan | Larut ing Dimethylformamide, meh ora larut ing banyu |
Kajelasan & Werna Solusi | Meet Requirement |
Identifikasi IR | Spektrum panyerepan inframerah kudu konsisten karo bahan referensi |
Identifikasi HPLC | Wektu penylametan puncak utama kudu konsisten karo referensi |
Rotasi spesifik | +142,0°~+149,0° |
Titik Lebur | ~140,0 ℃ |
Kandungan Air (KF) | <1.00% |
Sisa ing Ignition | <0,10% |
Related Impurities | (HPLC) |
Nitrogen Oksida | <0,10% |
Sulfon | <0,40% |
Sulfida | <0,20% |
Sembarang Impurity Single Liyane | <0,10% |
Total Impurities | <0,60% |
Kemurnian Optik (HPLC) | > 99,5% |
Assay | 98.0~102.0% (HPLC, %w/w, kanthi basis anhidrat, bebas pelarut) |
Logam abot | <10 ppm |
Sisa Solvents | |
Toluene | <890 ppm |
n-Heptana | <5000ppm |
Bakteri Endotoksin | <2.5EU/mg |
Test Standar | Standar USP;Pharmacopoeia Cina |
Panggunaan | API;Inhibitor Pompa Proton Oral Aktif |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
(R)-Lansoprazole (CAS: 138530-94-6) yaiku R enantiomer saka Lansoprazole, Lansoprazole (AG 1749) minangka inhibitor pompa proton aktif lisan sing nyegah lambung ngasilake asam.Dexlansoprazole kanggo Lansoprazole dextroisomer, punika jenis obatan ulcer peptik kanggo turunan benzimidazole diganti, ing struktur molekul menyang fluorine unsur, inhibitor pump proton kapindho omeprazole sawise.Dexlansoprazole duweni efek nyandhet sekresi asam lambung, efek luwih apik tinimbang obat liyane (Omeprazole, Pantoprazole, Rebela, Tetrazolium) bisa nyandhet kedadeyan ulcer.Luwih unggul tinimbang famotidine utawa Omeprazole kanggo ngrusak mukosa lambung sing disebabake alkohol lan ulkus duodenum sing utamane amarga hipersekresi asam.Kajaba iku, produk kasebut duwe efek anti Helicobacter pylori sing padha karo persiapan bismut, lan digunakake kanggo refluks esophagitis lan sindrom Zhuo AI.Takeda Pharmaceuticals nampa persetujuan saka dexlansoprazole, formulasi dual release saka (R) -isomer saka lansoprazole proton pump inhibitor (PPI) wis ing pasar, saka FDA ing Januari 2009. Dexlansoprazole punika kapsul release telat kanggo oncedaily, perawatan lisan heartburn gadhah gejala non-erosive gastroesophageal reflux disease (GERD), penyembuhan erosive esophagitis (EE) lan pangopènan EE waras.